ストックスクリーナーアプリを入手
16.76
1.12%
-0.19
前日終値:
$16.95
開ける：
$17.14
24時間の取引高:
1.57M
Relative Volume:
1.24
時価総額：
$2.87B
収益：
-
当期純損益:
$-382.71M
株価収益率:
-6.3969
EPS:
-2.62
ネットキャッシュフロー:
$-325.64M
1週間 パフォーマンス:
-5.31%
1か月 パフォーマンス:
+4.10%
6か月 パフォーマンス:
-23.92%
1年 パフォーマンス:
-42.41%
1日の値動き範囲:
$16.62
$17.49
1週間の範囲:
$15.31
$18.64
52週間の値動き範囲:
$12.72
$34.47
Immunovant Inc Stock (IMVT) Company Profile
IMVT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IMVT
Immunovant Inc
|
16.76 | 2.90B | 0 | -382.71M | -325.64M | -2.62 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.83 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.63 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
324.79 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
595.19 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.51 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Immunovant Inc Stock (IMVT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-10 | 再開されました | Goldman | Neutral |
| 2025-03-03 | 開始されました | Jefferies | Hold |
| 2025-01-03 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2024-10-10 | 再開されました | Raymond James | Outperform |
| 2024-10-09 | 繰り返されました | Oppenheimer | Outperform |
| 2024-03-28 | 開始されました | Oppenheimer | Outperform |
| 2024-03-13 | 開始されました | Goldman | Buy |
| 2024-02-20 | 開始されました | JP Morgan | Overweight |
| 2024-02-15 | 開始されました | Wolfe Research | Outperform |
| 2023-12-12 | 開始されました | Deutsche Bank | Buy |
| 2023-10-13 | アップグレード | UBS | Neutral → Buy |
| 2023-09-26 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2023-05-01 | 開始されました | BofA Securities | Buy |
| 2023-04-25 | 開始されました | Citigroup | Buy |
| 2023-03-31 | 開始されました | Piper Sandler | Overweight |
| 2023-03-30 | 開始されました | Stifel | Buy |
| 2023-02-15 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-02-13 | アップグレード | Guggenheim | Neutral → Buy |
| 2023-01-03 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2022-09-26 | ダウングレード | UBS | Buy → Neutral |
| 2021-12-08 | 開始されました | Wells Fargo | Equal Weight |
| 2021-08-03 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2021-08-02 | ダウングレード | Credit Suisse | Neutral → Underperform |
| 2021-06-01 | ダウングレード | Guggenheim | Buy → Neutral |
| 2021-06-01 | ダウングレード | Stifel | Buy → Hold |
| 2020-10-28 | 開始されました | UBS | Buy |
| 2020-10-12 | 開始されました | Guggenheim | Buy |
| 2020-10-08 | 開始されました | Stifel | Buy |
| 2020-10-02 | 開始されました | Credit Suisse | Outperform |
| 2020-08-26 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-08-25 | 開始されました | Raymond James | Outperform |
| 2020-07-29 | 開始されました | H.C. Wainwright | Buy |
| 2020-02-24 | 開始されました | SVB Leerink | Outperform |
すべてを表示
Immunovant Inc (IMVT) 最新ニュース
Is Immunovant Inc. stock overvalued or undervaluedEntry Signal Forecasts For Consistent Profits - jammulinksnews.com
Immunovant Inc. stock volume spike explainedFree Fast Return Equity Trade Forecast - Newser
Immunovant Inc. stock daily chart insightsFree Risk Controlled Short Term Trade Plans - Newser
Can momentum traders help lift Immunovant Inc.Chart Driven Entry Timing for Swing Trades - Newser
How volatile is Immunovant Inc. stock compared to the marketDiscover stocks with explosive growth potential - jammulinksnews.com
Immunovant Inc. Company Revenue and Profit Trends: A Deep DiveFree Real-Time Stock Data - metal.it
What are analysts’ price targets for Immunovant Inc. in the next 12 monthsRapid-fire capital growth - jammulinksnews.com
What institutional investors are buying Immunovant Inc. stockNavigate the market with precision tools - jammulinksnews.com
What is the dividend policy of Immunovant Inc. stockInvest smarter with real-time trading signals - jammulinksnews.com
Bank of New York Mellon Corp Reduces Holdings in Immunovant, Inc. (NASDAQ:IMVT) - Defense World
Immunovant Executives Sell Shares to Cover Tax Obligations - TradingView
Can Immunovant Inc. stock recover from recent declineHigh-profit stock alerts - jammulinksnews.com
LifeSci Capital Maintains a Buy on Immunovant (IMVT) With a $50 PT - MSN
Is Immunovant Inc. a good long term investmentExceptional gains - PrintWeekIndia
What drives Immunovant Inc. stock priceHigh-profit stock alerts - Autocar Professional
What analysts say about Immunovant Inc. stockTremendous wealth creation - Autocar Professional
Why Immunovant Inc. stock attracts strong analyst attentionFree Daily Stock Market Updates - Newser
How high can Immunovant Inc. stock price go in 2025Free Smart Trading Workshop - jammulinksnews.com
Immunovant, Inc. (NASDAQ:IMVT) Shares Purchased by Arizona State Retirement System - Defense World
Immunovant Inc. Stock Analysis and ForecastRecord-setting profit potential - jammulinksnews.com
Teacher Retirement System of Texas Buys 2,919 Shares of Immunovant, Inc. (NASDAQ:IMVT) - Defense World
why immunovant inc. stock attracts strong analyst attentionFree Access to Community - Newser
September 19th Options Now Available For Immunovant (IMVT) - Nasdaq
(IMVT) Trading Advice - news.stocktradersdaily.com
All You Need to Know About Immunovant (IMVT) Rating Upgrade to Buy - Yahoo Finance
Goldman Sachs Resumes Coverage of Immunovant (IMVT) with a Hold Rating - MSN
Wall Street Analysts See a 137.68% Upside in Immunovant (IMVT): Can the Stock Really Move This High? - Yahoo Finance
12 Oversold NASDAQ Stocks to Buy Now - Insider Monkey
What makes Immunovant Inc. stock price move sharplyShort Squeeze Radar - Newser
How Immunovant Inc. stock performs during market volatilityFree Trading Strategy Suggestions - Newser
Immunovant Inc (IMVT) 財務データ
収益
当期純利益
現金流量
EPS
1.32%
1.06%
大文字化:
|
ボリューム (24 時間):